title: Predicted vs Observed Clinical Event Risk for Cardiovascular Disease-Reply.
authors.affiliation: Cardiology Division, NorthShore University Health System, Evanston, Illinois.
authors.forename: Amit
authors.initials: A
authors.lastname: Pursnani
authors.affiliation: Framingham Heart Study of the National Heart, Lung, and Blood Institute, Framingham, Massachusetts.
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Massaro
authors.affiliation: Cardiac MR PET CT Program, Massachusetts General Hospital, Boston.
authors.forename: Udo
authors.initials: U
authors.lastname: Hoffmann
mesh_terms: D002114:Calcinosis / Q000188:drug therapy*; D003324:Coronary Artery Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008297:Male; D017410:Practice Guidelines as Topic
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors